Teneille Gofton, MD FRCPC
Assistant Professor, Western University
Office: London Health Sciences Centre, University Hospital B10-106
Secretary: Gina Hunter
Dr. Teneille Gofton completed medical school in Halifax, Nova Scotia at Dalhousie University in 2005. She then finished a Neurology Residency at Western University in London, Ontario in 2010. Dr. Gofton has two years of fellowship subspecialty training. The first year of fellowship training focused on Hospice and Palliative Medicine and was completed in 2011 at Memorial Sloan-Kettering Cancer Centre in New York, New York. The second year of fellowship training focused on Neurocritical Care, which Dr. Gofton completed under the mentorship of Dr. Young at Western University and during which she obtained certification for electroencephalography.
Dr. Gofton joined the faculty in the Department of Clinical Neurological Sciences at Western University in July of 2012. She specializes in and Palliative Care for patients living with neurological illnesses and in adult Neurocritical Care.
Dr. Gofton research interests focus on palliative care for patients living with chronic and progressive neurological disorders. She also participates in research regarding the care of critically neurological patients in the intensive care unit.
Dementia, Intensive Care
Honours and Awards
- 2017, 1st place Research Project, Advanced Learning in Palliative Medicine 2017 Annual Conference
- 2015, Teaching Honour Roll, Western University Students' Council
- 2012, Dr. John Brown Award for Patient-Centred Care, Western University
- 2009, Francis McNaughton Memorial Prize, Canadian Neurological Society
Dayal AM, Jenkins ME, Jog MS, Kimpinski K, MacDonald P, Gofton TE. Palliative Care Discussions in Multiple System Atrophy: A Retrospective Review. Can J Neurol Sci. 2017 May;44(3):276-282. doi: 10.1017/cjn.2016.439. Epub 2017 Feb 7. PMID: 28166857
Norton L, Gibson RM, Gofton T, Benson C, Dhanani S, Shemie SD, Hornby L, Ward R, Young GB. Electroencephalographic Recordings During Withdrawal of Life-Sustaining Therapy Until 30 Minutes After Declaration of Death. Can J Neurol Sci. 2017 Mar;44(2):139-145. doi: 10.1017/cjn.2016.309. PMID: 28231862